021-51111890
购物车（）
sales@molnova.cn
Bendazac
CAS No. 20187-55-7
Bendazac ( Bendazolic acid;AF-983 )
产品货号. M21078 CAS No. 20187-55-7
Bendazac is an anticataract drug. It may act by preventing protein denaturation.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 100MG | ￥332 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Bendazac
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述Bendazac is an anticataract drug. It may act by preventing protein denaturation.
-
产品描述Bendazac is an anticataract drug. It may act by preventing protein denaturation.
-
同义词Bendazolic acid;AF-983
-
通路Others
-
靶点Other Targets
-
受体Others
-
研究领域——
-
适应症——
化学信息
-
CAS Number20187-55-7
-
分子量282.29
-
分子式C16H14N2O3
-
纯度>98% (HPLC)
-
溶解度DMSO:56 mg/mL (198.38 mM)
-
SMILESO=C(O)COc1nn(Cc2ccccc2)c2ccccc12
-
化学全称2-((1-benzyl-1H-indazol-3-yl)oxy)acetic acid
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Marques C Ramalho J S Pereira P et al. Bendazac decreases in vitro glycation of human lens crystallins. Decrease of in vitro protein glycation by bendazac[J]. Documenta Ophthalmologica 1995 90(4):395-404.
产品手册
关联产品
-
Enalapril IMpurity B
Organic synthesis, pharmaceutical intermediates, can be used in the synthesis of maleic acid enalaprilat (anti-hypertension).
-
Setmelanotide TFA
Setmelanotide TFA (RM-493 TFA; BIM-22493 TFA; IRC-022493 TFA) is a selective melanocortin 4 receptor (MC4R) agonist.
-
Methyl 2,6-dichlorob...
Methyl 2,6-dichlorobenzoate is a biochemical compound that is used for proteomics research.
